Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlson, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlson, S. E.

Arachidonic Acid Status of Human Infants: Influence of Gestational Age at Birth and Diets with Very Long Chain n-3 and n-6 Fatty Acids1,2,

Susan E. Carlson3

Departments of Pediatrics, Obstetrics and Gynecology and Biochemistry, The University of Tennessee, Memphis, Memphis, TN 38163

In three randomized, double-blind clinical trials, preterm infants were fed typical preterm or term formulas and experimental formulas supplemented with n-3 and n-6 long-chain fatty acids. The effect of these feedings on the concentration of plasma phosphatidylcholine arachidonic acid (AA), an indicator of AA status, was contrasted with equivalent data from infants born at term. Preterm infants appear to have poorer AA status than breast-fed term infants at the corrected ages of 0 and 2 mo. The addition of marine oil elcosapentaenoic acid (EPA) (0.3%) and docosahexaenoic acid (DHA) (0.2%) to formula further decreased AA status (Study 1). The same amount of marine oil DHA (0.2%) but with less EPA (0.06%) fed for a shorter interval did not decrease plasma phosphatidylcholine AA concentration compared with controls (Study 2). Preterm infants fed both AA (0.43%) and DHA (0.1%) had better AA status than controls. These observations are discussed in relation to evidence from these same studies that AA status and the n-6/n-3 rates are related to growth of preterm infants.


KEY WORDS: • human infants • diet • arachidonic acid • n-3 fatty acid • growth

1 Presented as part of the symposium "Biological Effects of Dietary Arachidonic Acid" given at the Experimental Biology '95 meeting, Atlanta, GA, on April 11, 1995. This symposium was sponsored by the American Institute of Nutrition and was supported by a grant from the Cayman Chemical Company. Guest editors for the symposium were Jay Whelan, University of Tennessee, Knoxville, TN, and J. Bruce German, University of California, Davis, CA.

2 Supported by NIH R01 EY08770, NIH R01 HD31329 and gifts from Ross Products Division, Abbott Laboratories, Columbus, OH.

3 To whom correspondence should be addressed: Newborn Center, Room 201, 853 Jefferson Avenue, Memphis, TN 38163.




This article has been cited by other articles:


Home page
PediatricsHome page
I. B. Helland, L. Smith, B. Blomen, K. Saarem, O. D. Saugstad, and C. A. Drevon
Effect of Supplementing Pregnant and Lactating Mothers With n-3 Very-Long-Chain Fatty Acids on Children's IQ and Body Mass Index at 7 Years of Age
Pediatrics, August 1, 2008; 122(2): e472 - e479.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 1996 by American Society for Nutrition